Trademark: 98087704
Word
TEMPUS AI
Status
Pending
Status Code
688
Status Date
Tuesday, April 23, 2024
Serial Number
98087704
Mark Type
4
Filing Date
Monday, July 17, 2023
Published for Opposition
Tuesday, February 27, 2024

Trademark Owner History
TEMPUS AI, INC. - Owner At Publication
Tempus Labs, Inc. - Original Applicant

Classifications
9 Downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology, electrophysiology, oncology, neurology, and mental health; downloadable and recorded computer software using artificial intelligence for machine learning for supporting clinical data platforms for cardiac diagnostics and electrophysiology
44 Medical services; genetic and health information analysis and diagnostics for medical purposes; providing an Internet website portal featuring patient health information in the fields of oncology, electrophysiology, cardiology, neurology, and mental health; medical services in the fields of cardiology, electrophysiology, oncology, neurology, and mental health diagnostics and testing; providing medical diagnostic testing that analyzes patient samples and creates genomic data from the analysis
42 Platform as a service (PAAS) featuring computer software platforms for medical access to patient health information; Providing a web site featuring technology that enables users to access patient health information; Software as a service (SAAS) services featuring software for medical access to patient health information; Platform as a service (PaaS) featuring computer software platforms for voice command and recognition software, speech to text conversion software, and voice-enabled software applications for information management in the field of electronic health records relating to oncology, cardiology, neurology, and mental health; Providing temporary use of online non-downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Medical research; Medical and scientific research in the fields of genomics, genomic sequencing and genomic analysis; Software as a Service (SaaS) services featuring software for the review and analysis of medical images in the fields of radiology and pathology that provides actionable insights to add clinical value, improve diagnostic decision making, efficiency, and productivity, in the fields of oncology, cardiology, neurology, and mental health; medical and scientific research in the fields of diabetes, cardiology, neurology, oncology, electrophysiology, and mental health; providing medical and scientific research information in the fields of diabetes, cardiology, neurology, oncology, electrophysiology, and mental health; medical and scientific research and development services in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; computer system design and analysis for use in cardiology, neurology, oncology, electrophysiology, and mental health; software development for cardiac diagnostics and cardiology and electrophysiology; platform as a service (PAAS) services featuring computer software platforms for operating cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring software for cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; platform as a service (PAAS) services featuring computer software platforms employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; providing a website featuring on-line non-downloadable software that enables users to analyze genome sequences for disease assessment, prediction of medical and clinical outcomes, medical and clinical research, and drug development; providing a website featuring on-line non-downloadable software that enables users to collect, organize, and store genetic and genomic information of medical patients for diagnosis and treatment assistance; database development services, namely, curating, managing and organizing data libraries of genomic and medical information for healthcare professionals in cloud computing application systems; software as a service (SAAS) services featuring software for genomic sequencing, genomic related data analysis, and data management for hospitals and research centers; clinical research in the field of genomics; Structural and functional analysis of genomes; computer system design for use in oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; platform as a service (PAAS) services featuring computer software platforms for operating clinical decision support in the fields of diabetes, neurology, and mental health diagnostics and testing; software as a service (SAAS) services featuring software for clinical decision support in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; platform as a service (PAAS) featuring computer software platforms for clinical decision support in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing
TEMPUS A I; TEMPUS ARTIFICIAL INTELLIGENCE
"AI"

Trademark Events
Jul 20, 2023
New Application Entered
Aug 15, 2023
New Application Office Supplied Data Entered
Oct 18, 2023
Assigned To Examiner
Oct 21, 2023
Non-Final Action Written
Oct 21, 2023
Non-Final Action E-Mailed
Oct 21, 2023
Notification Of Non-Final Action E-Mailed
Nov 28, 2023
Teas Change Of Owner Address Received
Nov 28, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 28, 2023
Teas Change Of Correspondence Received
Jan 17, 2024
Automatic Update Of Assignment Of Ownership
Jan 21, 2024
Teas Response To Office Action Received
Jan 21, 2024
Correspondence Received In Law Office
Jan 22, 2024
Teas/Email Correspondence Entered
Jan 23, 2024
Examiners Amendment -Written
Jan 23, 2024
Examiners Amendment E-Mailed
Jan 23, 2024
Notification Of Examiners Amendment E-Mailed
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Jan 23, 2024
Examiner's Amendment Entered
Jan 23, 2024
Approved For Pub - Principal Register
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Apr 23, 2024
Noa E-Mailed - Sou Required From Applicant
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24